Overview

Sitagliptin Umbilical Cord Blood Transplant Study

Status:
Completed

Trial end date:
2015-02-01

Target enrollment:

Participant gender:

Summary

The main purpose of this trial is to study whether the drug sitagliptin can be given safely to patients undergoing umbilical cord blood transplantation to speed up engraftment (recovery of blood counts after transplant).

Phase:

Phase 2

Details

Lead Sponsor:

Indiana University School of Medicine

Treatments:

Sitagliptin Phosphate